The World Today - Thursday, 13 December
ELEANOR HALL: The asbestos disease, mesothelioma, is usually a death sentence, killing its victims within a year But an Adelaide mother has defied the medical odds by not only surviving the deadly asbestos-related disease mesothelioma but having a child 10 years after her diagnosis।39-year-old Belinda Dunn took part in a gene therapy trial soon after she received the news she had mesothelioma।But medical experts are still baffled by her survival, as Nance Haxton reports from Adelaide.
NANCE HAXTON: Belinda Dunn is a medical mystery. Her only contact with deadly asbestos dust was as a small child when she played on a pile of fibro while her parents were extending their house. The 39-year-old Adelaide mother of one was diagnosed with mesothelioma soon after the birth of her first child, Nathan, 10 years ago, and told she had little chance of living beyond a year. But a decade on, not only has she survived the disease, but she is pregnant as well.
BELINDA DUNN: It's a very daunting thought, actually. Where I was 10 years ago to where I am now.
NANCE HAXTON: Belinda Dunn took part in an experimental gene therapy trial in the United States soon after her diagnosis. But she says she doesn't credit her current good health exclusively to that treatment.
BELINDA DUNN: I've taken lots and lots of vitamins at the time of - under the guidance of my naturopath - with the gene therapy trial, and I'm just wondering if it was because my immune system was in good shape when I had the trial that perhaps that's helped it
NANCE HAXTON: And you've had no complications with the pregnancy from the mesothelioma so far?
BELINDA DUNN: Well, not from - not anything I've had normally for the last 10 years, because I suffer, still, like an arthritic type pain, like shoulder tip pain and I know when my mesothelioma is active, if you want to call it that, or it's my chest is inflamed and basically, I just live with that. And that's part of being pregnant and having mesothelioma.
NANCE HAXTON: Professor Doug Henderson from the Flinders Medical Centre in Adelaide was the doctor who initially diagnosed Belinda Dunn with mesothelioma. He says he never would have thought 10 years on from that day that he would be talking about her still being alive and well.
DOUG HENDERSON: I certainly didn't - it's a very unexpected but very positive and good outcome
NANCE HAXTON: But Professor Henderson says sadly, Belinda Dunn's recovery cannot be explained by science, and therefore has little significance at this stage for other sufferers.
DOUG HENDERSON: I have seen other rare cases of mesothelioma that have gone into apparently spontaneous complete remission and one patient whom I remember very vividly was alive with a completely normal chest X-ray and otherwise well, eight years after the diagnosis had been made.
NANCE HAXTON: What can this be put down to?
DOUG HENDERSON: We don't know the reasons for spontaneous regression like this in tumors. It might be due to some altered cellular dynamics within the tumor itself, but why that should happen we really have no clear idea. The other theory is that the immune system of a body somehow gains a boost and gains ascendancy over the tumor and puts it into remission.
NANCE HAXTON: So are there any ramifications from these rare cases that could be applied to other victims of this disease?
DOUG HENDERSON: I don't think so, these are the exceptions rather than the rule and I'm not sure that one could use these people or any factor from these people to treat other patients, because we don't know what the factors that are involved in this type of remission really are. I think only time will tell the eventual outcome but I hope that Belinda will have a virtually normal life expectancy, taking into account that she's now been in apparently complete remission with no evidence of progressive disease for some 10 years.
NANCE HAXTON: While Ms Dunn is grateful for her health, she struggles with losing many of the friends she has made through asbestos disease support groups, including Bernie Banton. She hopes that her case, while something of a miracle, gives hope to other people with mesothelioma - which it does not have to be a death sentence.
BELINDA DUNN: I really hope, you know, that that's what it's doing because, you know, if it's worked for me, surely someone will start thinking about what I had been doing with the vitamins when I had my trial and perhaps they can move on to do some research into what I was taking when I had the gene therapy, and perhaps someone else might be lucky and live with mesothelioma.
That's the mystery mesothelioma survivor, Belinda Dunn.
Showing posts with label MESOTHELIOMA NEWS. Show all posts
Showing posts with label MESOTHELIOMA NEWS. Show all posts
Thursday, December 13, 2007
Tuesday, December 11, 2007
MESOTHELIOMA NEWS; Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
In our quest to finding a lasting solution to mesothelioma, hope seems not to be lost.
Earlier this year Rosetta Genomics, Ltd. announced that it had partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung and mesothelioma cancers.
The early detection test will mainly target over 45 million Americans who are at an increased risk of lung cancer due to smoking, as well as those who have been exposed to asbestos fibers. The test will utilize Rosetta Genomics' proprietary protocol to extract microRNAs from a simple blood draw.
"A test that will be able to detect cancer at an early stage using a simple blood draw will have far reaching implications on the fight against cancer," noted Dr. Harvey Pass, Professor and Chief, Division of Thoracic Surgery and Thoracic Oncology at NYU Medical Center.
"MicroRNAs have been shown to hold great potential as effective biomarkers for various cancers, and I believe that NYU Medical Center's vast experience with lung cancer and Mesothelioma, coupled with Rosetta Genomics' expertise in the microRNA field, will allow us to successfully advance this much needed test forward."
This new development will help in future diagnoses and for lasting treatment for the rare deadly disease. Other firms are also developing new treatment options, but for now, I think one has to avoid asbestos as possible as one can, to prevent contacting this disease.
Earlier this year Rosetta Genomics, Ltd. announced that it had partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung and mesothelioma cancers.
The early detection test will mainly target over 45 million Americans who are at an increased risk of lung cancer due to smoking, as well as those who have been exposed to asbestos fibers. The test will utilize Rosetta Genomics' proprietary protocol to extract microRNAs from a simple blood draw.
"A test that will be able to detect cancer at an early stage using a simple blood draw will have far reaching implications on the fight against cancer," noted Dr. Harvey Pass, Professor and Chief, Division of Thoracic Surgery and Thoracic Oncology at NYU Medical Center.
"MicroRNAs have been shown to hold great potential as effective biomarkers for various cancers, and I believe that NYU Medical Center's vast experience with lung cancer and Mesothelioma, coupled with Rosetta Genomics' expertise in the microRNA field, will allow us to successfully advance this much needed test forward."
This new development will help in future diagnoses and for lasting treatment for the rare deadly disease. Other firms are also developing new treatment options, but for now, I think one has to avoid asbestos as possible as one can, to prevent contacting this disease.
Subscribe to:
Posts (Atom)